Actively Recruiting
Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-03
29
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not clear. For interpretation of longitudinal lung function data it is important to examine the short time effect of chest physiotherapy. We hypothesize that a session of chest physiotherapy improves lung function and that thus lung function tests must be performed in a standardized way.
CONDITIONS
Official Title
Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of primary ciliary dyskinesia
- Able to perform spirometry and multiple breath washout tests (age over 6 years)
You will not qualify if you...
- Acute exacerbation of respiratory symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Gasthuisberg Leuven
Leuven, Belgium, 3000
Actively Recruiting
Research Team
M
Mieke Boon, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here